At present, we found that EBV-miR-BART1-5P activates the AMPK/mTOR/HIF1 pathway by targeting AMPKα1 to upregulate the glycolysis of NPC cells, to induce angiogenesis, and ultimately to promote the growth of NPC cells. Here, PRKAA1 is linked to nasopharyngeal carcinoma.